Susquehanna raised the firm’s price target on Helmerich & Payne to $40 from $36 and keeps a Positive rating on the shares. The firm updated it model following Q1 results where EBITDA and free cash flow were above expectations. Management stated that it remains optimistic for its full-year outlook due to ongoing customer discussions but sees greater upside potential in 2027 and beyond.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HP:
- Helmerich & Payne reports Q1 EPS (15c), consensus 11c
- HP Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Helmerich & Payne price target raised to $28 from $26 at Morgan Stanley
- HP (HPQ) Options Trade Flashes Courtesy of Resurgent PC Market
- Helmerich & Payne price target raised to $34 from $29 at RBC Capital